-
Trump meets with pharma execs at White House
WASHINGTON — Executives from several pharmaceutical companies and the Pharmaceutical Research and Manufacturers of America convened at the White House Tuesday for a meeting with President Donald Trump, Vice President Mike Pence and House Energy and Commerce Committee chairman Rep. Greg Walden, R-Ore. The president kicked off the meeting by mentioning the price of drugs and the need for competition in the marketplace.Report: Generics bill introduced in House
Sunshine State News is reporting that U.S. Reps. Gus Bilirakis, R-Fla., and Kurt Schrader, D-Ore., have introduced the Lower Drug Costs Through Competition Act, which is aimed at encouraging generics makers to develop generics of products with little or no competition, or for drugs that are in short supply. The bill calls for the creation of a Priority Review Voucher for generics applications filed for drugs that have no current competition. The bill was referred to the House Energy and Commerce Committee Monday, and eight representatives have signed on.